Targeting the Vessel Underdogs: Therapeutic Approaches for Microvessel Dysfunction in the Heart

Amanda Jo LeBlanc1, Christopher D Nevitt2

  • 1Department of Physiology, Cardiovascular Innovation Institute, University of Louisville, Kentucky.

Insights

Coronary microvascular dysfunction contributes to heart disease. This review explores therapeutic strategies and tissue engineering advances to improve heart microcirculation and function.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Regenerative Medicine

Background:

  • The role of coronary microcirculation in heart disease is increasingly recognized.
  • The Women's Ischemia Syndrome Evaluation study highlighted the importance of microvascular function.
  • Previous tissue engineering efforts often overlooked vascular components in myocardial repair.

Purpose of the Study:

  • To define the role of coronary microcirculation in heart disease development.
  • To review therapeutic approaches for reversing coronary microvascular dysfunction.
  • To discuss advances in tissue engineering that incorporate functional microvasculature.

Main Methods:

  • Literature review of coronary microvascular disease.
  • Analysis of therapeutic interventions for microvascular dysfunction.
  • Examination of tissue engineering strategies for myocardial regeneration.

Main Results:

  • Coronary microvascular dysfunction is a significant factor in heart disease.
  • Various therapeutic strategies have shown limited or unsuccessful outcomes.
  • Tissue engineering is advancing to include functional microcirculation in cardiac constructs.

Conclusions:

  • Understanding and targeting coronary microvascular dysfunction is crucial for heart disease treatment.
  • Future research should focus on integrating functional microvasculature into cardiac tissue engineering.
  • Developing effective therapies for coronary microvascular disease remains a key challenge.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
470
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
499
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
363
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
506
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584